Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Nestler

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Comparative Effectiveness Research|March 28, 2024
Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedemaMax Schlueter, Sandra Nestler-Parr
Food Additives and Contaminants|December 8, 2005
Renal tumourigenesis in male rats in response to chronic dietary ochratoxin APeter Mantle, Elena Kulinskaya, Sandra Nestler
Orphanet Journal of Rare Diseases|January 25, 2023
A survey exploring caregiver burden and health-related quality of life in hereditary transthyretin amyloidosisSarah Acaster, Siu Hing Lo, Sandra Nestler-Parr
Food Additives and Contaminants|December 8, 2005
Ochratoxin A: potential epigenetic mechanisms of toxicity and carcinogenicityBenoît Schilter, Maricel Marin-Kuan, Thierry Delatour, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 18, 2017
Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials: An ISPOR COA Emerging Good Practices Task Force ReportKaty Benjamin, Margaret K Vernon, Donald L Patrick, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 28, 2015
Rare Disease Terminology and Definitions-A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest GroupTrevor Richter, Sandra Nestler-Parr, Robert Babela, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 22, 2025
Long-Term Prophylactic Treatment Preferences and Willingness to Switch Therapy in Individuals With Hereditary AngioedemaCourtney Olson, Michael Lionetti, Christine Poulos, et al.
Nature Communications|June 5, 2025
Terahertz field effect in a two-dimensional semiconductorTomoki Hiraoka, Sandra Nestler, Wentao Zhang, et al.
Nature Communications|January 17, 2026
Publisher Correction: Terahertz field effect in a two-dimensional semiconductorTomoki Hiraoka, Sandra Nestler, Wentao Zhang, et al.
Allergy and Asthma Proceedings|April 29, 2025
Adherence and persistence among patients with hereditary angioedema receiving long-term prophylaxis in the United StatesBruce L Zuraw, Lorena Lopez-Gonzalez, Janna Manjelievskaia, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Comparative Effectiveness Research|March 28, 2024
Letter to the editor: network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedemaMax Schlueter, Sandra Nestler-Parr
Food Additives and Contaminants|December 8, 2005
Renal tumourigenesis in male rats in response to chronic dietary ochratoxin APeter Mantle, Elena Kulinskaya, Sandra Nestler
Orphanet Journal of Rare Diseases|January 25, 2023
A survey exploring caregiver burden and health-related quality of life in hereditary transthyretin amyloidosisSarah Acaster, Siu Hing Lo, Sandra Nestler-Parr
Food Additives and Contaminants|December 8, 2005
Ochratoxin A: potential epigenetic mechanisms of toxicity and carcinogenicityBenoît Schilter, Maricel Marin-Kuan, Thierry Delatour, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 18, 2017
Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials: An ISPOR COA Emerging Good Practices Task Force ReportKaty Benjamin, Margaret K Vernon, Donald L Patrick, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 28, 2015
Rare Disease Terminology and Definitions-A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest GroupTrevor Richter, Sandra Nestler-Parr, Robert Babela, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 22, 2025
Long-Term Prophylactic Treatment Preferences and Willingness to Switch Therapy in Individuals With Hereditary AngioedemaCourtney Olson, Michael Lionetti, Christine Poulos, et al.
Nature Communications|June 5, 2025
Terahertz field effect in a two-dimensional semiconductorTomoki Hiraoka, Sandra Nestler, Wentao Zhang, et al.
Nature Communications|January 17, 2026
Publisher Correction: Terahertz field effect in a two-dimensional semiconductorTomoki Hiraoka, Sandra Nestler, Wentao Zhang, et al.
Allergy and Asthma Proceedings|April 29, 2025
Adherence and persistence among patients with hereditary angioedema receiving long-term prophylaxis in the United StatesBruce L Zuraw, Lorena Lopez-Gonzalez, Janna Manjelievskaia, et al.
Pageof 2